Meanwhile, the extent of methylation the ZSCAN18 promoter was relatively higher for the luminal (n = 393), HER2-positive (n = 17), and TNBC (n = 84) subtypes of BC than normal tissues (n = 97) (p < 0.001) (Figure 4D). Here, ZSCAN18 is linked to breast cancer.